

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 5.38903110 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.00531986 |
| 3 | actin filament-based movement (GO:0030048) | 4.88711081 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.83391868 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.80483773 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.74823191 |
| 7 | locomotory exploration behavior (GO:0035641) | 4.69113909 |
| 8 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.65420237 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.58616851 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.53620643 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.52921158 |
| 12 | vocalization behavior (GO:0071625) | 4.50165091 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.47308863 |
| 14 | glutamate secretion (GO:0014047) | 4.46827625 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.39303425 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.32252474 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.24933294 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.15682847 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.08831663 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.07351139 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.07041827 |
| 22 | response to muscle activity (GO:0014850) | 4.03051293 |
| 23 | skeletal muscle fiber development (GO:0048741) | 3.99058509 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.96441322 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.93197748 |
| 26 | response to inactivity (GO:0014854) | 3.90797339 |
| 27 | cell communication by electrical coupling (GO:0010644) | 3.90182146 |
| 28 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.89289984 |
| 29 | actomyosin structure organization (GO:0031032) | 3.88919637 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.86978581 |
| 31 | muscle contraction (GO:0006936) | 3.83469801 |
| 32 | protein localization to synapse (GO:0035418) | 3.81313681 |
| 33 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.80735380 |
| 34 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.79203622 |
| 35 | regulation of synaptic vesicle transport (GO:1902803) | 3.78398809 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.73669028 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.73615889 |
| 38 | cardiac myofibril assembly (GO:0055003) | 3.73469213 |
| 39 | creatine metabolic process (GO:0006600) | 3.73011144 |
| 40 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.70556845 |
| 41 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.70425742 |
| 42 | myotube cell development (GO:0014904) | 3.69101338 |
| 43 | regulation of cell communication by electrical coupling (GO:0010649) | 3.67118349 |
| 44 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.66037067 |
| 45 | muscle filament sliding (GO:0030049) | 3.63222459 |
| 46 | actin-myosin filament sliding (GO:0033275) | 3.63222459 |
| 47 | muscle cell cellular homeostasis (GO:0046716) | 3.59955504 |
| 48 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.59878051 |
| 49 | synaptic transmission, glutamatergic (GO:0035249) | 3.59723260 |
| 50 | regulation of membrane repolarization (GO:0060306) | 3.56764656 |
| 51 | cardiac muscle contraction (GO:0060048) | 3.56455196 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 3.56097710 |
| 53 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.52338522 |
| 54 | muscle fiber development (GO:0048747) | 3.50096896 |
| 55 | neurotransmitter secretion (GO:0007269) | 3.49868923 |
| 56 | exploration behavior (GO:0035640) | 3.48078671 |
| 57 | plasma membrane repair (GO:0001778) | 3.45795120 |
| 58 | neuron-neuron synaptic transmission (GO:0007270) | 3.45469750 |
| 59 | sarcomere organization (GO:0045214) | 3.44630206 |
| 60 | myofibril assembly (GO:0030239) | 3.44350588 |
| 61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.43203479 |
| 62 | cardiac muscle cell development (GO:0055013) | 3.42601167 |
| 63 | muscle system process (GO:0003012) | 3.42424985 |
| 64 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.40799083 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 3.37426198 |
| 66 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.36365200 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.36365200 |
| 68 | detection of calcium ion (GO:0005513) | 3.35900951 |
| 69 | regulation of striated muscle contraction (GO:0006942) | 3.35763972 |
| 70 | long-term memory (GO:0007616) | 3.34976671 |
| 71 | neuromuscular synaptic transmission (GO:0007274) | 3.34577387 |
| 72 | membrane depolarization during action potential (GO:0086010) | 3.33832544 |
| 73 | activation of protein kinase A activity (GO:0034199) | 3.32318362 |
| 74 | sodium ion export (GO:0071436) | 3.31203175 |
| 75 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.31102275 |
| 76 | regulation of sarcomere organization (GO:0060297) | 3.29679693 |
| 77 | negative regulation of protein localization to cell surface (GO:2000009) | 3.27182611 |
| 78 | cell communication involved in cardiac conduction (GO:0086065) | 3.26479093 |
| 79 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.25651903 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.25651903 |
| 81 | striated muscle contraction (GO:0006941) | 3.23674773 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 3.19686387 |
| 83 | regulation of synaptic plasticity (GO:0048167) | 3.16659074 |
| 84 | cardiac cell development (GO:0055006) | 3.16342315 |
| 85 | regulation of the force of heart contraction (GO:0002026) | 3.16033444 |
| 86 | neuron cell-cell adhesion (GO:0007158) | 3.14380548 |
| 87 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.12124165 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.10806024 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 3.10570500 |
| 90 | postsynaptic membrane organization (GO:0001941) | 3.10409852 |
| 91 | positive regulation of synapse maturation (GO:0090129) | 3.09349674 |
| 92 | positive regulation of membrane potential (GO:0045838) | 3.08630458 |
| 93 | adult heart development (GO:0007512) | 3.04901600 |
| 94 | long-term synaptic potentiation (GO:0060291) | 3.03121243 |
| 95 | striated muscle cell development (GO:0055002) | 3.02880067 |
| 96 | muscle tissue morphogenesis (GO:0060415) | 3.01796783 |
| 97 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.01551029 |
| 98 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.01017437 |
| 99 | muscle hypertrophy (GO:0014896) | 2.99813182 |
| 100 | potassium ion import (GO:0010107) | 2.99747697 |
| 101 | layer formation in cerebral cortex (GO:0021819) | 2.99189589 |
| 102 | myotube differentiation (GO:0014902) | 2.99023944 |
| 103 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.98718359 |
| 104 | regulation of actin filament-based movement (GO:1903115) | 2.95777133 |
| 105 | regulation of skeletal muscle contraction (GO:0014819) | 2.94792514 |
| 106 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.94746944 |
| 107 | skeletal muscle tissue development (GO:0007519) | 2.94555671 |
| 108 | striated muscle adaptation (GO:0014888) | 2.94151979 |
| 109 | NADH metabolic process (GO:0006734) | 2.93365775 |
| 110 | cardiac conduction (GO:0061337) | 2.93064262 |
| 111 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.93035922 |
| 112 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.92811875 |
| 113 | membrane depolarization (GO:0051899) | 2.92726559 |
| 114 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.92099816 |
| 115 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.91796874 |
| 116 | muscle hypertrophy in response to stress (GO:0003299) | 2.91796874 |
| 117 | cardiac muscle adaptation (GO:0014887) | 2.91796874 |
| 118 | regulation of cation channel activity (GO:2001257) | 2.90917509 |
| 119 | regulation of dendritic spine development (GO:0060998) | 2.90657841 |
| 120 | actin-mediated cell contraction (GO:0070252) | 2.90459651 |
| 121 | regulation of transmembrane transporter activity (GO:0022898) | 2.90390759 |
| 122 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89857878 |
| 123 | cardiac muscle hypertrophy (GO:0003300) | 2.89150615 |
| 124 | gamma-aminobutyric acid transport (GO:0015812) | 2.88842667 |
| 125 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.86174198 |
| 126 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.85084624 |
| 127 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.84706510 |
| 128 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.84035328 |
| 129 | tricarboxylic acid cycle (GO:0006099) | 2.83610702 |
| 130 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.83427585 |
| 131 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.83050416 |
| 132 | striated muscle hypertrophy (GO:0014897) | 2.81889499 |
| 133 | heart contraction (GO:0060047) | 2.81370954 |
| 134 | heart process (GO:0003015) | 2.81370954 |
| 135 | myoblast fusion (GO:0007520) | 2.81339227 |
| 136 | positive regulation of neurotransmitter transport (GO:0051590) | 2.81165909 |
| 137 | regulation of neurotransmitter secretion (GO:0046928) | 2.80947658 |
| 138 | neuromuscular process controlling balance (GO:0050885) | 2.79933552 |
| 139 | striatum development (GO:0021756) | 2.79257328 |
| 140 | regulation of relaxation of muscle (GO:1901077) | 2.78666774 |
| 141 | relaxation of muscle (GO:0090075) | 2.77558501 |
| 142 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.75914309 |
| 143 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.74035725 |
| 144 | glycogen catabolic process (GO:0005980) | 2.73161838 |
| 145 | relaxation of cardiac muscle (GO:0055119) | 2.66667204 |
| 146 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.62813018 |
| 147 | muscle structure development (GO:0061061) | 2.62392124 |
| 148 | muscle organ development (GO:0007517) | 2.62277650 |
| 149 | muscle cell fate commitment (GO:0042693) | 2.61524927 |
| 150 | skeletal muscle adaptation (GO:0043501) | 2.59772535 |
| 151 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.57983597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.19668749 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21380376 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04464131 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00646820 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86797809 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.78986336 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69606627 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69606627 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.55491283 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50124613 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48715325 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47050996 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45669819 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40033065 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.38101825 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34866431 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.34785706 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17271543 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16060781 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10562094 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07969858 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05271571 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.04046054 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.96560509 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95834916 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73989943 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66951857 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.63638508 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61158539 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60898665 |
| 31 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.58849982 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57984135 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52891480 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50468698 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50101962 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49790171 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49010330 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48023373 |
| 39 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.47276958 |
| 40 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46878729 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45636930 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42090405 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42000747 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39937970 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39647146 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36349667 |
| 47 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36336416 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35268681 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33228816 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32082182 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31935708 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30399004 |
| 53 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29043530 |
| 54 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29043530 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28630821 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28520002 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26473593 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25618498 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24798938 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23151122 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22452970 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22244282 |
| 63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20218311 |
| 64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.19677912 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16857678 |
| 66 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.16377510 |
| 67 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.15710303 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15095748 |
| 69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14557438 |
| 70 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13940642 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12571606 |
| 72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12289679 |
| 73 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11598178 |
| 74 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11233243 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11179194 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11126595 |
| 77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10660367 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09393473 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08853295 |
| 80 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08133402 |
| 81 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08067502 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07108441 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06979153 |
| 84 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05710798 |
| 85 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05710798 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05253941 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03675981 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03545337 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03008445 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02330327 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01552674 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00812809 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00335776 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00286304 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00270977 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99709402 |
| 97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98911897 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98047737 |
| 99 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97395503 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97126192 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95987695 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94854695 |
| 103 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94622050 |
| 104 | * FUS_26573619_Chip-Seq_HEK293_Human | 0.94420102 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94214880 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93973755 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93739520 |
| 108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93690269 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93550241 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93155704 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93111989 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92348145 |
| 113 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91934620 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91718099 |
| 115 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.91106750 |
| 116 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89986548 |
| 117 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89769749 |
| 118 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89538821 |
| 119 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88380501 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88008633 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87672276 |
| 122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87498106 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86112226 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84470814 |
| 125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83742395 |
| 126 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82767273 |
| 127 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80864854 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.80695660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.86524341 |
| 2 | MP0003880_abnormal_central_pattern | 4.00589930 |
| 3 | MP0000751_myopathy | 3.50539210 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.47651779 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.45799268 |
| 6 | MP0004270_analgesia | 3.22964904 |
| 7 | MP0003646_muscle_fatigue | 3.10870867 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.91956470 |
| 9 | MP0009745_abnormal_behavioral_response | 2.88024688 |
| 10 | MP0002822_catalepsy | 2.76696333 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.76254021 |
| 12 | MP0000749_muscle_degeneration | 2.74588929 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.66548715 |
| 14 | MP0002064_seizures | 2.60511092 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.53861720 |
| 16 | MP0009046_muscle_twitch | 2.53810010 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.52925347 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.25981752 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.22585823 |
| 20 | MP0002272_abnormal_nervous_system | 2.12732707 |
| 21 | MP0001486_abnormal_startle_reflex | 2.01514677 |
| 22 | MP0005620_abnormal_muscle_contractility | 1.91688541 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 1.90146452 |
| 24 | MP0005330_cardiomyopathy | 1.80369209 |
| 25 | MP0002736_abnormal_nociception_after | 1.78039664 |
| 26 | MP0004484_altered_response_of | 1.77061467 |
| 27 | MP0004087_abnormal_muscle_fiber | 1.75600774 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.74562354 |
| 29 | MP0003137_abnormal_impulse_conducting | 1.73602253 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.70789766 |
| 31 | MP0008569_lethality_at_weaning | 1.69984109 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.69871286 |
| 33 | MP0004233_abnormal_muscle_weight | 1.69511220 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.68439213 |
| 35 | MP0002972_abnormal_cardiac_muscle | 1.66898178 |
| 36 | MP0000747_muscle_weakness | 1.64551370 |
| 37 | MP0004085_abnormal_heartbeat | 1.62249398 |
| 38 | MP0004130_abnormal_muscle_cell | 1.59917212 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.59023755 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.54685675 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.53392521 |
| 42 | MP0002269_muscular_atrophy | 1.49381426 |
| 43 | MP0005369_muscle_phenotype | 1.43093386 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.42820398 |
| 45 | MP0004924_abnormal_behavior | 1.42820398 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.42395286 |
| 47 | MP0002735_abnormal_chemical_nociception | 1.41869247 |
| 48 | MP0000733_abnormal_muscle_development | 1.39441728 |
| 49 | MP0004510_myositis | 1.38084131 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.36064867 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.35954427 |
| 52 | MP0003329_amyloid_beta_deposits | 1.35154365 |
| 53 | MP0001299_abnormal_eye_distance/ | 1.34007243 |
| 54 | MP0001970_abnormal_pain_threshold | 1.30626880 |
| 55 | MP0003879_abnormal_hair_cell | 1.28770017 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.27887862 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.23596664 |
| 58 | MP0004858_abnormal_nervous_system | 1.21756447 |
| 59 | MP0006138_congestive_heart_failure | 1.20773084 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.20483393 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.20298881 |
| 62 | MP0010030_abnormal_orbit_morphology | 1.19645466 |
| 63 | MP0000750_abnormal_muscle_regeneration | 1.17636513 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.14330973 |
| 65 | MP0002184_abnormal_innervation | 1.13459123 |
| 66 | MP0003633_abnormal_nervous_system | 1.10992606 |
| 67 | MP0000013_abnormal_adipose_tissue | 1.09409987 |
| 68 | MP0001529_abnormal_vocalization | 1.09138444 |
| 69 | MP0005385_cardiovascular_system_phenoty | 1.09091517 |
| 70 | MP0001544_abnormal_cardiovascular_syste | 1.09091517 |
| 71 | MP0001984_abnormal_olfaction | 1.09026819 |
| 72 | MP0000778_abnormal_nervous_system | 1.03094163 |
| 73 | MP0003122_maternal_imprinting | 1.00827882 |
| 74 | MP0000955_abnormal_spinal_cord | 1.00438485 |
| 75 | MP0002882_abnormal_neuron_morphology | 0.98903507 |
| 76 | MP0001346_abnormal_lacrimal_gland | 0.96185830 |
| 77 | MP0003787_abnormal_imprinting | 0.95640364 |
| 78 | MP0010630_abnormal_cardiac_muscle | 0.95252577 |
| 79 | MP0004147_increased_porphyrin_level | 0.94949108 |
| 80 | MP0005187_abnormal_penis_morphology | 0.88739131 |
| 81 | MP0001502_abnormal_circadian_rhythm | 0.88737357 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.88287867 |
| 83 | MP0003631_nervous_system_phenotype | 0.85710776 |
| 84 | MP0008874_decreased_physiological_sensi | 0.85602566 |
| 85 | MP0004142_abnormal_muscle_tone | 0.85295541 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.84403515 |
| 87 | MP0001905_abnormal_dopamine_level | 0.82194241 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.81776244 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.81338156 |
| 90 | MP0004885_abnormal_endolymph | 0.80286789 |
| 91 | MP0005451_abnormal_body_composition | 0.79134817 |
| 92 | MP0002102_abnormal_ear_morphology | 0.77754577 |
| 93 | MP0005171_absent_coat_pigmentation | 0.77535645 |
| 94 | MP0002127_abnormal_cardiovascular_syste | 0.77226659 |
| 95 | MP0003075_altered_response_to | 0.76963699 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.76482352 |
| 97 | MP0005535_abnormal_body_temperature | 0.75427139 |
| 98 | MP0006276_abnormal_autonomic_nervous | 0.74752633 |
| 99 | MP0002152_abnormal_brain_morphology | 0.74282776 |
| 100 | MP0000534_abnormal_ureter_morphology | 0.72905330 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.71767274 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.70786204 |
| 103 | MP0004043_abnormal_pH_regulation | 0.69885935 |
| 104 | MP0003136_yellow_coat_color | 0.68785600 |
| 105 | MP0008872_abnormal_physiological_respon | 0.67024254 |
| 106 | MP0003385_abnormal_body_wall | 0.66771603 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.66665003 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.62810350 |
| 109 | MP0001177_atelectasis | 0.62441518 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.62140696 |
| 111 | MP0000762_abnormal_tongue_morphology | 0.61894627 |
| 112 | MP0002971_abnormal_brown_adipose | 0.61881512 |
| 113 | MP0003123_paternal_imprinting | 0.61021196 |
| 114 | MP0002229_neurodegeneration | 0.60734071 |
| 115 | MP0005266_abnormal_metabolism | 0.60646429 |
| 116 | MP0009250_abnormal_appendicular_skeleto | 0.60324351 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.60107775 |
| 118 | MP0000372_irregular_coat_pigmentation | 0.58442661 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.57518875 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56969934 |
| 121 | MP0000266_abnormal_heart_morphology | 0.55998384 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.55793479 |
| 123 | MP0002090_abnormal_vision | 0.53417822 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.52824241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.53887919 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.55085403 |
| 3 | Myokymia (HP:0002411) | 5.20139645 |
| 4 | Sudden death (HP:0001699) | 5.07096985 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 4.76112514 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.72342474 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.71925339 |
| 8 | Focal seizures (HP:0007359) | 4.35066850 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 4.00358300 |
| 10 | Visual hallucinations (HP:0002367) | 3.83985843 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.83385956 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 3.76203376 |
| 13 | Atonic seizures (HP:0010819) | 3.62960620 |
| 14 | Calcaneovalgus deformity (HP:0001848) | 3.62357993 |
| 15 | Atrial fibrillation (HP:0005110) | 3.51542933 |
| 16 | Bundle branch block (HP:0011710) | 3.43949360 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 3.40207041 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 3.38594472 |
| 19 | Febrile seizures (HP:0002373) | 3.35823390 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 3.31436654 |
| 21 | Ventricular fibrillation (HP:0001663) | 3.27260682 |
| 22 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.27110207 |
| 23 | Supraventricular tachycardia (HP:0004755) | 3.23898428 |
| 24 | Deformed tarsal bones (HP:0008119) | 3.22919003 |
| 25 | Absence seizures (HP:0002121) | 3.21144082 |
| 26 | Syncope (HP:0001279) | 3.20409017 |
| 27 | Muscle fiber splitting (HP:0003555) | 3.15352424 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.15264301 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 3.13255246 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 3.12668047 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 3.11103561 |
| 32 | Prolonged QT interval (HP:0001657) | 3.10847455 |
| 33 | Myoglobinuria (HP:0002913) | 3.08634917 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.08026964 |
| 35 | Subaortic stenosis (HP:0001682) | 3.08026964 |
| 36 | Absent phalangeal crease (HP:0006109) | 3.05961116 |
| 37 | Distal lower limb muscle weakness (HP:0009053) | 3.04674034 |
| 38 | Myotonia (HP:0002486) | 3.03939708 |
| 39 | Broad-based gait (HP:0002136) | 3.03221884 |
| 40 | Progressive cerebellar ataxia (HP:0002073) | 2.96657600 |
| 41 | Difficulty running (HP:0009046) | 2.96000661 |
| 42 | Dialeptic seizures (HP:0011146) | 2.92740412 |
| 43 | Dysmetric saccades (HP:0000641) | 2.92428076 |
| 44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.89301356 |
| 45 | Poor eye contact (HP:0000817) | 2.87727387 |
| 46 | Areflexia of lower limbs (HP:0002522) | 2.84826852 |
| 47 | Nemaline bodies (HP:0003798) | 2.84661218 |
| 48 | Hyperventilation (HP:0002883) | 2.81398978 |
| 49 | Frequent falls (HP:0002359) | 2.80091658 |
| 50 | Abnormal EKG (HP:0003115) | 2.79195589 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.77566427 |
| 52 | Ventricular arrhythmia (HP:0004308) | 2.77154955 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.68842594 |
| 54 | Ventricular tachycardia (HP:0004756) | 2.68356487 |
| 55 | Gowers sign (HP:0003391) | 2.63536315 |
| 56 | Action tremor (HP:0002345) | 2.63518604 |
| 57 | Abnormal social behavior (HP:0012433) | 2.58138786 |
| 58 | Impaired social interactions (HP:0000735) | 2.58138786 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.57868400 |
| 60 | Heart block (HP:0012722) | 2.57800400 |
| 61 | Popliteal pterygium (HP:0009756) | 2.57324107 |
| 62 | Depression (HP:0000716) | 2.54873171 |
| 63 | Anxiety (HP:0000739) | 2.52065116 |
| 64 | Pheochromocytoma (HP:0002666) | 2.49149862 |
| 65 | Abnormal finger flexion creases (HP:0006143) | 2.47533528 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.41639649 |
| 67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.41414435 |
| 68 | Weak cry (HP:0001612) | 2.41123616 |
| 69 | Abnormal atrioventricular conduction (HP:0005150) | 2.36546304 |
| 70 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.35623443 |
| 71 | Amblyopia (HP:0000646) | 2.35458831 |
| 72 | Dysmetria (HP:0001310) | 2.34813981 |
| 73 | Round ear (HP:0100830) | 2.34261045 |
| 74 | Fatigable weakness (HP:0003473) | 2.31133006 |
| 75 | Abnormality of the neuromuscular junction (HP:0003398) | 2.31133006 |
| 76 | Ankle clonus (HP:0011448) | 2.28911203 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.28243029 |
| 78 | Distal arthrogryposis (HP:0005684) | 2.26952472 |
| 79 | Generalized muscle weakness (HP:0003324) | 2.26574202 |
| 80 | Left ventricular hypertrophy (HP:0001712) | 2.25094426 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.24944522 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.23953220 |
| 83 | Postural instability (HP:0002172) | 2.22692877 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 2.21007042 |
| 85 | Scapular winging (HP:0003691) | 2.20194673 |
| 86 | Atrioventricular block (HP:0001678) | 2.19490488 |
| 87 | Type 2 muscle fiber atrophy (HP:0003554) | 2.19340140 |
| 88 | Urinary urgency (HP:0000012) | 2.19124654 |
| 89 | Lipoatrophy (HP:0100578) | 2.17444852 |
| 90 | Muscle stiffness (HP:0003552) | 2.17316832 |
| 91 | Difficulty climbing stairs (HP:0003551) | 2.15353471 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.15151855 |
| 93 | Hip contracture (HP:0003273) | 2.13681429 |
| 94 | Truncal ataxia (HP:0002078) | 2.07086203 |
| 95 | Neck muscle weakness (HP:0000467) | 2.03433110 |
| 96 | Abnormality of the calcaneus (HP:0008364) | 2.02209909 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 2.01122491 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.99347122 |
| 99 | Myopathic facies (HP:0002058) | 1.99293940 |
| 100 | Right ventricular cardiomyopathy (HP:0011663) | 1.98452497 |
| 101 | Impaired vibratory sensation (HP:0002495) | 1.98161444 |
| 102 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98133750 |
| 103 | Proximal amyotrophy (HP:0007126) | 1.94904836 |
| 104 | Genetic anticipation (HP:0003743) | 1.94790693 |
| 105 | Resting tremor (HP:0002322) | 1.93990280 |
| 106 | Palpitations (HP:0001962) | 1.93921820 |
| 107 | Increased connective tissue (HP:0009025) | 1.93191323 |
| 108 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.92432658 |
| 109 | Abnormality of the lower motor neuron (HP:0002366) | 1.92166119 |
| 110 | Slender build (HP:0001533) | 1.91274724 |
| 111 | EMG: neuropathic changes (HP:0003445) | 1.89151464 |
| 112 | Muscle fiber atrophy (HP:0100295) | 1.89041000 |
| 113 | Bulbar palsy (HP:0001283) | 1.88538302 |
| 114 | Spinal rigidity (HP:0003306) | 1.87964077 |
| 115 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.86685178 |
| 116 | Dilated cardiomyopathy (HP:0001644) | 1.86310292 |
| 117 | Scanning speech (HP:0002168) | 1.82687258 |
| 118 | Shoulder girdle muscle weakness (HP:0003547) | 1.82148093 |
| 119 | Foot dorsiflexor weakness (HP:0009027) | 1.82037077 |
| 120 | Rapidly progressive (HP:0003678) | 1.81959177 |
| 121 | Rhabdomyolysis (HP:0003201) | 1.80259500 |
| 122 | Impaired smooth pursuit (HP:0007772) | 1.78905076 |
| 123 | Incomplete penetrance (HP:0003829) | 1.78737846 |
| 124 | Abnormal eating behavior (HP:0100738) | 1.77693421 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76353899 |
| 126 | Amniotic constriction ring (HP:0009775) | 1.76289634 |
| 127 | Abnormality of placental membranes (HP:0011409) | 1.76289634 |
| 128 | Central scotoma (HP:0000603) | 1.75637847 |
| 129 | Rimmed vacuoles (HP:0003805) | 1.75348097 |
| 130 | Akinesia (HP:0002304) | 1.75292560 |
| 131 | Bradykinesia (HP:0002067) | 1.74175890 |
| 132 | Progressive inability to walk (HP:0002505) | 1.74060899 |
| 133 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.73951080 |
| 134 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.73951080 |
| 135 | Limb-girdle muscle weakness (HP:0003325) | 1.72613355 |
| 136 | Muscular dystrophy (HP:0003560) | 1.71367353 |
| 137 | Limited hip movement (HP:0008800) | 1.69806904 |
| 138 | Waddling gait (HP:0002515) | 1.67671315 |
| 139 | Nonprogressive disorder (HP:0003680) | 1.67594391 |
| 140 | Steppage gait (HP:0003376) | 1.66027932 |
| 141 | Delayed gross motor development (HP:0002194) | 1.63515565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.82446274 |
| 2 | NTRK3 | 3.85880402 |
| 3 | OBSCN | 2.86474896 |
| 4 | MAP3K9 | 2.85704911 |
| 5 | MAP3K4 | 2.66778658 |
| 6 | DAPK2 | 2.45730874 |
| 7 | PHKG1 | 2.25645692 |
| 8 | PHKG2 | 2.25645692 |
| 9 | PRKD3 | 2.24219782 |
| 10 | LIMK1 | 2.20978291 |
| 11 | MAP2K7 | 2.08664353 |
| 12 | MINK1 | 2.01901536 |
| 13 | MAP2K4 | 1.96157132 |
| 14 | KSR2 | 1.94911083 |
| 15 | PAK6 | 1.94245385 |
| 16 | PDK3 | 1.76412253 |
| 17 | PDK4 | 1.76412253 |
| 18 | RIPK4 | 1.71813103 |
| 19 | TTN | 1.71759167 |
| 20 | KSR1 | 1.60818767 |
| 21 | DMPK | 1.60741041 |
| 22 | CAMKK1 | 1.60150685 |
| 23 | NEK1 | 1.58159682 |
| 24 | LMTK2 | 1.56021454 |
| 25 | DAPK1 | 1.55086925 |
| 26 | PINK1 | 1.53737083 |
| 27 | CASK | 1.51976461 |
| 28 | MAP3K12 | 1.51570995 |
| 29 | PIK3CG | 1.45622911 |
| 30 | STK38 | 1.39349625 |
| 31 | NTRK2 | 1.37214770 |
| 32 | PLK2 | 1.32378156 |
| 33 | CDK19 | 1.31216006 |
| 34 | NME1 | 1.29934833 |
| 35 | PRPF4B | 1.29757704 |
| 36 | CDK5 | 1.25772394 |
| 37 | PTK2B | 1.23586249 |
| 38 | MUSK | 1.22301891 |
| 39 | MARK1 | 1.20136818 |
| 40 | NTRK1 | 1.19786097 |
| 41 | ARAF | 1.14844495 |
| 42 | MYLK | 1.12711357 |
| 43 | CAMK2A | 1.08364043 |
| 44 | MAP3K7 | 1.06353931 |
| 45 | CAMK1 | 1.06182267 |
| 46 | PRKCG | 1.00398664 |
| 47 | TNIK | 0.99904649 |
| 48 | MAP3K13 | 0.97011940 |
| 49 | ERBB3 | 0.96370206 |
| 50 | GRK5 | 0.93417839 |
| 51 | TAOK1 | 0.93095941 |
| 52 | PDK2 | 0.93037324 |
| 53 | MOS | 0.88012383 |
| 54 | FES | 0.83649523 |
| 55 | SGK2 | 0.83591918 |
| 56 | PAK3 | 0.82421072 |
| 57 | CAMKK2 | 0.82414936 |
| 58 | PDK1 | 0.82267987 |
| 59 | RAF1 | 0.81133593 |
| 60 | SGK494 | 0.79624745 |
| 61 | SGK223 | 0.79624745 |
| 62 | CAMK2B | 0.79236093 |
| 63 | DAPK3 | 0.79144502 |
| 64 | CAMK2D | 0.77415617 |
| 65 | PIK3CA | 0.76934991 |
| 66 | SGK1 | 0.76233576 |
| 67 | MAPK12 | 0.75978351 |
| 68 | TYRO3 | 0.75959833 |
| 69 | WNK3 | 0.74937183 |
| 70 | SGK3 | 0.74800486 |
| 71 | PDPK1 | 0.74343581 |
| 72 | BMPR2 | 0.74296738 |
| 73 | TRIB3 | 0.73372696 |
| 74 | PRKCH | 0.72824413 |
| 75 | UHMK1 | 0.71887605 |
| 76 | CDK18 | 0.71642977 |
| 77 | STK11 | 0.71515454 |
| 78 | PNCK | 0.71011585 |
| 79 | PKN1 | 0.70728461 |
| 80 | MAPK13 | 0.69771299 |
| 81 | CDK15 | 0.68313949 |
| 82 | CCNB1 | 0.68129897 |
| 83 | CDC42BPA | 0.67844932 |
| 84 | TESK1 | 0.66977664 |
| 85 | MAPKAPK3 | 0.65239831 |
| 86 | MAP3K2 | 0.64723113 |
| 87 | CDK14 | 0.64385756 |
| 88 | SIK2 | 0.63531067 |
| 89 | NEK9 | 0.62842489 |
| 90 | TRIM28 | 0.62774144 |
| 91 | RET | 0.60813137 |
| 92 | STK38L | 0.60338422 |
| 93 | PKN2 | 0.59919608 |
| 94 | PRKG1 | 0.59332957 |
| 95 | CAMK2G | 0.59277911 |
| 96 | CAMK4 | 0.58921499 |
| 97 | CDK11A | 0.56971579 |
| 98 | OXSR1 | 0.55929260 |
| 99 | MAP3K1 | 0.55654799 |
| 100 | PRKAA1 | 0.54777812 |
| 101 | LATS2 | 0.52685124 |
| 102 | RIPK1 | 0.52595886 |
| 103 | DYRK1B | 0.50981114 |
| 104 | RPS6KA3 | 0.49430069 |
| 105 | STK24 | 0.49069840 |
| 106 | ROCK1 | 0.48376855 |
| 107 | AKT2 | 0.48339150 |
| 108 | BCR | 0.47113076 |
| 109 | DYRK1A | 0.46457233 |
| 110 | PRKCE | 0.45605035 |
| 111 | MAPK10 | 0.44345119 |
| 112 | MAP2K1 | 0.44337687 |
| 113 | ROCK2 | 0.43412616 |
| 114 | FER | 0.43073456 |
| 115 | EPHB2 | 0.42207212 |
| 116 | WNK1 | 0.41537924 |
| 117 | MAP3K5 | 0.39789588 |
| 118 | CSNK1G2 | 0.37531774 |
| 119 | PRKACA | 0.35406904 |
| 120 | BRSK1 | 0.35031263 |
| 121 | BRAF | 0.34280291 |
| 122 | MARK2 | 0.33843329 |
| 123 | PRKAA2 | 0.32756709 |
| 124 | STK39 | 0.31736060 |
| 125 | MAPK4 | 0.31289457 |
| 126 | PRKACB | 0.30825682 |
| 127 | WEE1 | 0.29922734 |
| 128 | PBK | 0.28854806 |
| 129 | TRPM7 | 0.26638232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.01343484 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63396439 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58654202 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.58644307 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.54458454 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.44783310 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35120806 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30432489 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.25589646 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21625715 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18939738 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.18675533 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.15555128 |
| 14 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.03304327 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.00251592 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.92731725 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.92009471 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90130679 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88832329 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88279580 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.87266517 |
| 22 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74002614 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73999955 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.73030595 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65462368 |
| 26 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45525557 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44175686 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.43592541 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.41704103 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.39467390 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.38527440 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36610049 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35167148 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28881554 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27403566 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26730178 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21967521 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.17159202 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16745487 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15261184 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11473499 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11165083 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09220333 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07977291 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.07208722 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06487359 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06157892 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05771763 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05706200 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00129583 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98747245 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95937246 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.94003339 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92039796 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.91969891 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87793509 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85398542 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79531459 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79390644 |
| 60 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79099541 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77373183 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76849576 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76246880 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73947621 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73366005 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72472859 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71671239 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.70584993 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70161532 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69879705 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69242789 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69171093 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68762142 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67546904 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66296948 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64919090 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63916163 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63062270 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62866374 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62492986 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62377395 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.61970947 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61592279 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61234645 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61106644 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60977013 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59749197 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58587808 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58322684 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56615838 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55048236 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.52880912 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52553473 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51370674 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50973400 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50528599 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50133356 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48386192 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47027828 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46003963 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.45392738 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45088827 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44169042 |
| 104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43770537 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43641116 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43470145 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43343391 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43148739 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41916042 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41859450 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41253181 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40992194 |
| 113 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40730901 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39655037 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39545769 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.39189238 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39131501 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37642054 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37300406 |
| 120 | Bile secretion_Homo sapiens_hsa04976 | 0.36464988 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35039878 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.34523695 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31315849 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30979757 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30779838 |
| 126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29853287 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29587369 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28886500 |

